abstract |
The present invention provides novel pyridyl- and phenyl-ureas and analogs thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides several pharmaceutical compositions thereof and methods for treating diseases sensitive to modulation of the activity of the P2Y1 receptor. |